Company Announcements - 2021
Notice of Extraordinary General Meeting17 May 2021
Notice is given that an Extraordinary General Meeting will be held at 10am on Friday, 18 June 2021 in the Mayflower Room, 320 Adelaide Street, Brisbane, Australia
Form 60430 April 2021
Notice of change of interests of substantial holders Dr Michael Monsour and Dr Peter Corr.
US Patent Grant for PeriCoach30 April 2021
Analytica announces the granting of patent protection in the USA for motion sensing in pelvic floor exercise devices.
Appendix 4C29 April 2021
Analytica presents its quarterly cash flow report to 31 March 2021.
Notice under section 708A and Appendix 2A28 April 2021
Analytica has today issued 879,903,083 fully paid ordinary shares in the Company at an issue price of 0.35 cents per share.
Placement to Raise up to $3.83m23 April 2021
Analytica announce a share placement at an issue price of 0.35 cents per share which will raise up to $3.83 million subject to shareholder approval.
Trading Halt21 April 2021
ASX advises that Analytica securities have been placed in a trading halt pending an announcement regarding capital raising.
Expansion of Enhanced Infusion System into Middle East20 April 2021
Analytica has entered into an agreement with an Egyptian entity to distribute and market the EIS in Egypt, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia and UAE.
Half Year Report to 31 Dec 202031 March 2021
Analytica presents its audited Half year results to 31 December 2020.
Expansion into China with PeriCoach JV30 March 2021
Analytica has entered into a joint venture agreement to manufacture, distribute and market the system in China, Macau, Hong Kong and Taiwan
Appendix 4D and Half Year accounts lodged under ASX Extended Class waiver26 February 2021
Analytica presents its Appendix 4D - Half year results to 31 December 2020.
Appendix 4C29 January 2021
Analytica presents its quarterly cash flow report to 31 December 2020.